Synthetic lethality with BRAF/MEK inhibitors

Date 13 March 2015
Event ESMO Symposium on Signalling Pathways in Cancer 2015
Session Regulation of signalling pathway and therapeutic targeting
Topics Anti-Cancer Agents & Biologic Therapy
Translational Research
Presenter Roderick Beijersbergen
Authors R. Beijersbergen
  • Netherlands Cancer Institute, 1066CX - Amsterdam/NL